Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Prevalence and Risk Factors of Persistent SARS-CoV-2 Infection in Immunocompromised Patients

NCT06576102 is registered in ClinicalTrials.gov with Maddalena Giannella as lead sponsor.

NCT NCT06576102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06576102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Prevalence and Risk Factors of Persistent SARS-CoV-2 Infection in Immunocompromised Patients
Lead sponsor
Maddalena Giannella
Phase
Observational
Overall status
Completed
Start date
March 1, 2024
Completion date
December 31, 2025
Enrollment
204 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

b cell malignancies, persistent covid-19